Journal article
P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro
Genes & development, Vol.11(20), pp.2633-2644
10/15/1997
DOI: 10.1101/gad.11.20.2633
PMCID: PMC316604
PMID: 9334326
Abstract
To identify novel inhibitors of transcriptional activation by the HIV Tat protein, we used a combination of in vitro and in vivo Tat-dependent transcription assays to screen >100,000 compounds. All compounds identified blocked Tat-dependent stimulation of transcriptional elongation. Analysis of a panel of structurally diverse inhibitors indicated that their target is the human homolog of
Drosophila
positive transcription elongation factor b (P-TEFb). Loss of Tat transactivation in extracts depleted of the kinase subunit of human P-TEFb, PITALRE, was reversed by addition of partially purified human P-TEFb. Transfection experiments with wild-type or kinase knockout PITALRE demonstrated that P-TEFb is required for Tat function. Our results suggest that P-TEFb represents an attractive target for the development of novel HIV therapeutics.
Details
- Title: Subtitle
- P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro
- Creators
- Helena S.Y. Mancebo - Telik, Inc.Gary LeeJohn FlygareJoanne TomassiniPercy LuuYuerong ZhuJunmin PengCarol BlauDaria HazudaDavid PriceOsvaldo Flores
- Resource Type
- Journal article
- Publication Details
- Genes & development, Vol.11(20), pp.2633-2644
- DOI
- 10.1101/gad.11.20.2633
- PMID
- 9334326
- PMCID
- PMC316604
- NLM abbreviation
- Genes Dev
- ISSN
- 0890-9369
- eISSN
- 1549-5477
- Publisher
- Cold Spring Harbor Laboratory Press
- Language
- English
- Date published
- 10/15/1997
- Academic Unit
- Biochemistry and Molecular Biology
- Record Identifier
- 9984288721502771
Metrics
9 Record Views